SCHEMBL111498

SCHEMBL111498

CC(C)[Si](Oc1ccc(C(CN2C(=O)c3ccccc3C2=O)C(=O)O)cc1)(C(C)C)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
MEN1 O00255 1/20 0.39
THRB P10828 1/20 0.39
ALDH1A1 P00352 3/20 0.39
HTR1A P08908 1/20 0.39
ADRA1A P35348 1/20 0.39
NPC1 O15118 1/20 0.39
CA12 O43570 1/20 0.38
CA9 Q16790 1/20 0.38
MAPK1 P28482 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
LTA4H P09960 1/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
TNF P01375 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL112312 0.89 KMT2A (0.44) KMT2AMEN1THRBALDH1A1NPC1
SCHEMBL23501351 0.86 MAPK1 (0.44) KMT2AMEN1ALDH1A1HTR1AADRA1A
SCHEMBL114458 0.86 MAPK1 (0.44) KMT2AMEN1ALDH1A1HTR1AADRA1A
SCHEMBL23501346 0.84 KMT2A (0.40) KMT2AMEN1THRBALDH1A1HTR1A
SCHEMBL23501357 0.82 MAPK1 (0.38) KMT2AALDH1A1HTR1AADRA1AMAPK1
SCHEMBL23501359 0.82 MAPK1 (0.38) KMT2AALDH1A1HTR1AADRA1AMAPK1
SCHEMBL23501303 0.81 CYP3A4 (0.48) KMT2AMEN1THRBALDH1A1HTR1A
SCHEMBL7746342 0.80 CA12 (0.53) KMT2AMEN1THRBALDH1A1CA12
SCHEMBL23501237 0.80 TDP1 (0.41) KMT2AMEN1HTR1AADRA1AMAPK1
SCHEMBL23501328 0.77 ALDH1A1 (0.53) KMT2AALDH1A1HTR1AADRA1ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424842-A2 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE Aerie Pharmaceuticals, Inc. (US) 2012-03-07 EP disclosed
EP-2424857-A1 DUAL-ACTION INHIBITORS AND METHODS OF USING SAME Aerie Pharmaceuticals, Inc. (US) 2012-03-07 EP disclosed
WO-2010127330-A1 DUAL-ACTION INHIBITORS AND METHODS OF USING SAME AERIE PHAMACEUTICALS, INC. (US) 2010-11-04 WO disclosed
WO-2010127329-A1 DUAL-ACTION INHIBITORS AND METHODS OF USING SAME AERIE PHARMACEUTICALS, INC. (US) 2010-11-04 WO disclosed
WO-2010126626-A2 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE AERIE PHARMACEUTICALS, INC. (US) 2010-11-04 WO disclosed